Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate va...
Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: Results from the EBMT IDWP01 trial
About this item
Full title
Author / Creator
Cordonnier, Catherine , Labopin, Myriam , Chesnel, Virginie , Ribaud, Patricia , Camara, Rafael De La , Martino, Rodrigo , Ullmann, Andrew J , Parkkali, Terttu , Locasciulli, Anna , Yakouben, Karima , Pauksens, Karlis , Bonnet, Eric , Einsele, Hermann , Niederwieser, Dietger , Apperley, Jane and Ljungman, Per
Publisher
Netherlands: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Abstract The current recommendations for active immunization after stem cell transplant (SCT) include 3 doses of 7-valent pneumococcal conjugate vaccine (PCV7) from 3 months after transplant, followed by a 23-valent polysaccharide pneumococcal vaccine (PPV23). However, until now, the immune response to PPV23 after PCV7 has not been assessed after S...
Alternative Titles
Full title
Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: Results from the EBMT IDWP01 trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_swepub_ki_se_553440
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_553440
Other Identifiers
ISSN
0264-410X,1873-2518
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2010.01.025
